Skip to main content

Table 1 Patient characteristics

From: Feasibility of image-guided radiotherapy based on helical tomotherapy to reduce contralateral parotid dose in head and neck cancer

  

Study

Historical control

Total

Patient No

 

23

29

52

Age

 

Median

66

60

63

 

Range

25–92

26–90

25–92

Sex

 

Male

21

28

49

 

Female

2

1

3

 

Squamous histology

22

30

52

Tumor sites

 

Oropharynx

5

10

15

 

Oral cavity

7

8

15

 

Parotid (primary or metastates)

3

1

4

 

Larynx

4

6

10

 

Hypopharynx

2

2

4

 

Unknown

1

2

3

 

Nasopharynx

1

0

1

Stages

 

I

0

2

2

 

II

2

1

3

 

III

9

12

21

 

IVA

6

10

16

 

IVB

3

4

7

 

IVC

2

0

2

 

Recurrence

1

0

1

T stages

 

Tx

1

2

3

 

T1

1

4

5

 

T2

13

10

23

 

T3

3

8

11

 

T4

4

5

9

 

Recurrence

1

0

1

Neck nodes

 

N0

3

8

11

 

N1

13

9

22

 

N2

4

10

14

 

N3

2

2

4

 

Recurrence

1

0

1

Treatement

 

Radiotherapy alone

5

5

10

 

Chemoradiation

18

24

42

  1. Study: Mean parotid dose constraints less than 20 Gray; Control: Mean parotid dose constraints 26 Gy.